References
- World Alzheimer Report 2015. The global impact of dementia: An analysis of prevalence, incidence, cost and trends. Alzheimer’s disease international. https://www.alz.co.uk/research/world-report-2015.
- Bourgade K, Garneau H, Giroux G, et al. β-Amyloid peptides display protective activity against the human Alzheimer’s disease-associated herpes simplex virus-1. Biogeronthology. 2015;16(1):85–98.
- Harris SA, Harris EA. Herpes simplex virus type 1 and other pathogens are key causative factors in sporadic Alzheimer’s Disease. J Alzheimers Dis. 2015;48(2):319–353.
- Wisniewski HM, Moretz RC, Lossinsky AS. Evidence for induction of localized amyloid deposits and neuritic plaques by an infectious agent. Ann Neurol. 1981;10(6):517–522.
- Smith JS, Robinson NJ. Age-specific prevalence of infection with herpes simplex virus type 2 and 1: A global review. J Infect Dis. 2002;186:S3–28.
- Jamieson GA, Maitland NJ, Wilcock GK, et al. Latent herpes simplex virus type 1 in normal and Alzheimer’s disease brains. J Med Virol. 1991;33(4):224–227.
- Wozniak MA, Shipley SJ, Combrinck M, et al. Productive herpes virus in brain of elderly normal subjects and Alzheimer’s disease patients. J Med Virol. 2005;75(2):300–306.
- Ball MJ. Limbic predilection in Alzheimer dementia: is reactivated herpesvirus involved? Can J Neurol Sci. 1982;9(3):303–306.
- De chiara G, Marcocci ME, Civitelli L, et al. APP processing induced by herpes simplex virus type 1 (HSV-1) yields several APP fragments in human and rat neuronal cells. Plos One. 2010;5:e13989.
- Cheng SB, Ferland P, Webster P, et al. Herpes simplex virus dances with amyloid precursor protein while exiting the cell. Plos One. 2011;6:e17966.
- Wozniak MA, Frost AL, Itzhaki RF. Azheimer’s disease-specific tau phosphorylation is induced by herpes simplex virus type 1. J Alzheimers Dis. 2009;16(2):341–350.
- Itzhaki R, Lathe R, Balin BJ, et al. Microbes and Alzheimer’s disease. J Alzheimers Dis. 2016;51(4):979–984.
- Mancuso R, Baglio F, Cabinio M, et al. Titers of herpes simplex virus type 1 antibodies positively correlate with grey matter volumes in Alzheimer’s disease. J Alzheimers Dis. 2014;38(4):741–745.
- Agostini S, Clerici M, Mancuso R. How plausible is a link between HSV-1 infection and Alzheimer’s disease? Expert Rev Anti Infect Ther. 2014;12(3):275–278.
- Mancuso R, Baglio F, Agostini S, et al. Relationship between herpes simplex virus-1-specific antibody titers and cortical brain damage in Alzheimer’s disease and amnestic mild cognitive impairment. Front Aging Neurosci. 2014;6:285.
- Agostini S, Mancuso R, Baglio F, et al. Lack of evidence for a role of HHV-6 in the pathogenesis of Alzheimer’s disease. J Alzheimers Dis. 2015;49(1):229–235.
- Yoshikawa T, Asano Y. Central nervous system complications in human herpesvirus-6 infection. Brain Dev. 2000;22(5):307–314.
- Letteneur L, Peres K, Fleury H, et al. Seropositivity to herpes simplex virus antibodies and risk of Alzheimer’s disease: a population-based cohort study. Plos One. 2008;3(11):e3637.
- Lovheim H, Gilthorpe J, Adolfsson R, et al. Reactivated herpes simplex infection increases the risk of Alzheimer’s disease. Alzheimers Dement. 2015;11(6):593–599.
- Kobayashi N, Nagata T, Shinagawa S, et al. Increase in the IgG avidity index due to herpes simplex virus type 1 reactivation and its relationship with cognitive function in amnestic mild cognitive impairment and Alzheimer’s disease. Biochem Biophys Res Commun. 2013;430(3):907–911.
- Agostini S, Mancuso R, Baglio F, et al. High avidity HSV-1 antibodies correlate with absence of amnestic mild cognitive impairment conversion to Alzheimer’s disease. Brain Behav Immunol. 2016;58:254–260.
- La Rosa F, Saresella M, Piancone F, et al. Increased TLR8 and 9 expression correlates with preserved hippocampal volumes and lack of progression to AD in mild cognitive impairment individuals. J Alzheimers Dis. 2016;53:S34.
- Wozniak M, Bell T, Denes A, et al. Anti-HSV1 activity of brown algal polysaccharides and possible relevance to the treatment of Alzheimer’s disease. Int J Biol Macromol. 2015;74:530–540.
- Mori I. Anti-herpesviral activity of curcumin may attenuate the development of Alzheimer’s disease. Med Hypotheses. 2015;84(6):603.
- Sartori G, Jardim NS, Marcondes Sari MH, et al. Antiviral action of diphenyl diselenide on herpes simplex virus 2 infection in female BALB/c mice. J Cell Biochem. 2016;117(7):1638–1648.